Not applicableUnknownNCT06362863What this trial is testingEvaluation of Enteral Nutrition Biscuits for Inducing Remission in Moderate-to-severe Crohn's DiseaseWho this might be right forCrohn's Disease Ping An 52
Testing effectiveness (Phase 2)Study completedNCT00446433What this trial is testingEvaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's DiseaseWho this might be right forCrohn's Disease Celgene Corporation 90
Large-scale testing (Phase 3)Study completedNCT03398148What this trial is testingA Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis (UC) AbbVie 1,558
Large-scale testing (Phase 3)Looking for participantsNCT07196748What this trial is testingA Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative ColitisWho this might be right forColitis, Ulcerative Janssen Research & Development, LLC 882
Not applicableWithdrawnNCT02201758What this trial is testingFlaxseed Lignan-Enriched Complex (FLC) for the Treatment of Patients With Ulcerative Colitis (UC): A Pilot AssessmentWho this might be right forUlcerative Colitis University of Saskatchewan
Large-scale testing (Phase 3)Study completedNCT00409682What this trial is testingEfficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease Abbott 192
Large-scale testing (Phase 3)Ended earlyNCT03559517What this trial is testingEfficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)Who this might be right forCrohn's Disease Shire 30
Early research (Phase 1)Study completedNCT01831427What this trial is testingStudy to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative ColitisWho this might be right forUlcerative Colitis Gilead Sciences 74
Testing effectiveness (Phase 2)Study completedNCT00430898What this trial is testingBasiliximab in Moderate to Severe Ulcerative ColitisWho this might be right forUlcerative Colitis Cerimon Pharmaceuticals 181
Large-scale testing (Phase 3)UnknownNCT05181137What this trial is testingInvestigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis Reistone Biopharma Company Limited 368
Large-scale testing (Phase 3)Looking for participantsNCT07686081What this trial is testingStudy to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis (UC) Vanda Pharmaceuticals 150
Testing effectiveness (Phase 2)Study completedNCT01809275What this trial is testingSafety and Treatment Effect of QBECO in Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's DiseaseInflammatory Bowel Disease Qu Biologics Inc. 68
Testing effectiveness (Phase 2)Ended earlyNCT00329537What this trial is testingStudy of Sargramostim in Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Genzyme, a Sanofi Company 11
Testing effectiveness (Phase 2)Ended earlyNCT01716039What this trial is testingPharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis Alimentiv Inc. 22
Testing effectiveness (Phase 2)Study completedNCT00739986What this trial is testingSemapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus PlaceboWho this might be right forCrohn's Disease Ferring Pharmaceuticals 152
Large-scale testing (Phase 3)Ended earlyNCT00349752What this trial is testingCorticosteroid Sparing Effect of Certolizumab in Crohn's DiseaseWho this might be right forCrohn's Disease UCB Pharma 174
Not applicableStudy completedNCT02822235What this trial is testingNon-interventional Study of Moderate to Severe Inflammatory Bowel Disease in BrazilWho this might be right forInflammatory Bowel Disease Takeda 407
Testing effectiveness (Phase 2)Active Not RecruitingNCT06637631What this trial is testingInvestigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.Who this might be right forCrohn's Disease Sanofi 260
Testing effectiveness (Phase 2)Study completedNCT00072943What this trial is testingA Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's DiseaseColitisIntestinal Disease+2 more Facet Biotech 175
Testing effectiveness (Phase 2)Study completedNCT00138840What this trial is testingStudy of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease Synta Pharmaceuticals Corp. 282